Stemedica Cell Technologies, Inc.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 25.0

Forward Citations = 19

Loading Chart...

8 inventors (with patents filed for the assignee):

Alexander Kharazi (3 out of 4 patents)

Nikolai I Tankovich (2 out of 43 patents)

Alex Kharazi (1 out of 1 patent)

4. M G Muralidhar (1 out of 1 patent)

5. Grigory Vertelov (1 out of 1 patent)

6. Chih-Min Lin (1 out of 3 patents)

7. Ludmilla Kharazi (1 out of 1 patent)

8. Ludmila Kharazi (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 9080184 - Transgenic therapeutic stem cells and methods for their use and manufacture (2015-07-14),

2. 8790638 - Compositions of stem cells and stem cell factors and methods for their use and manufacture (2014-07-29),

3. 8709081 - Cellular scaffold (2014-04-29),

4. 8105380 - Cellular scaffold (2012-01-31),

Company Overview

Stemedica Cell Technologies, Inc. is a global biotechnology company that develops and manufactures adult allogeneic stem cells for use in clinical research and for the treatment of various diseases and disorders. Established in 2005, Stemedica is dedicated to advancing the field of regenerative medicine and improving patient outcomes. With a focus on collaboration and innovation, Stemedica is committed to bringing cutting-edge therapies to patients in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#1,008 in San Diego, CA

#14,058 in California

#60,671 in US

San Diego, CA, United States of America